Ascendis Pharma A/S (ASND) NASDAQ
221.78
-2.04(-0.91%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
221.78
-2.04(-0.91%)
Currency In USD
| Market Cap | 11B |
| Enterprise Value | 11.26B |
| P/E Ratio | -51.71 |
| PEG Ratio | -19.96 |
| Price/Sales Ratio | 16.4 |
| Price/Book Ratio | -72.35 |
| Enterprise/Revenue | 16.76 |
| Enterprise/EBITDA | -149.11 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.32 |
| Operating Margin | -0.19 |
| Return On Assets | -0.17 |
| Return On Equity | 1.28 |
| Revenue | 691.71M |
| Revenue/Share | 11.69 |
| Gross Profit | 588.53M |
| EBITDA | -113.9M |
| Net Income | -219.03M |
| Diluted EPS | -3.62 |
| Total Cash | 615.78M |
| Total Cash/Share | 10.03 |
| Total Debt | 871.41M |
| Total Debt/Equity | -5.35 |
| Current Ratio | 1.04 |
| Book Value Per Share | -2.65 |
| 52-Week Change | 35.86 |
| 52-Week High | 248.6 |
| 52-Week Low | 124.06 |
| Moving Average 50 Days | 225.26 |
| Moving Average 200 Days | 201.61 |
| Average Volume | 676,794 |
| Shares Outstanding | 61.38M |
| % Held by Institutions | 106.05 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |